CONCOMITANT HYPERTESION AND DYSLIPIDEMIA PATIENTS TREATED BBY EITHER FIXED-DOSE OR FREE-COMBINATION AMLODIPINE AND ATORVASTATIN

被引：0
|
作者：
Chu, Pao Hsien H.
Lin, Chia-Pin
机构：
来源：
HYPERTENSION | 2023年 / 80卷
关键词：
Outcomes; Hyperlipidemia; Hypertension; essential;
D O I：
10.1161/hyp.80.suppl_1.P345
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
AP345
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of atorvastatin plus amlodipine versus either agent alone in patients with concomitant dyslipidemia and hypertension: The AVALON study
    Flack, J
    Houston, M
    Neutel, J
    Ferrera, D
    Gillen, D
    Gibson, E
    JOURNAL OF HYPERTENSION, 2004, 22 : S12 - S12
  • [22] Strategic design and clinical evaluation of a fixed-dose combination tablet comprising valsartan, amlodipine, rosuvastatin and ezetimibe for patients with hypertension and dyslipidemia
    Tae-Kwang Kim
    Jeong-Eun Lee
    Kyuho Jeong
    Min-Jun Baek
    Dahan Kim
    Jun-Young Jeon
    Sangyoung Lee
    Dae-Duk Kim
    Journal of Pharmaceutical Investigation, 2024, 54 : 99 - 112
  • [23] EFFICACY AND SAFETY OF FIXED-DOSE COMBINATION OF ROSUVASTATIN AND IRBESARTAN IN PATIENTS WITH DYSLIPIDEMIA AND HYPERTENSION
    Kim, S. H.
    Lee, H. L.
    Kim, H. L.
    Seo, J. B.
    Chung, W. Y.
    Zo, J. H.
    Kim, M. A.
    Oh, B. H.
    ATHEROSCLEROSIS, 2014, 235 (02) : E264 - E264
  • [24] Efficacy and safety of fixed-dose combination of irbesartan/atorvastatin in patients with hypercholesterolemia and hypertension
    Kim, Sang-Hyun
    Lee, Hyang-Lim
    Kim, Hack-Lyoung
    Lim, Woo-Hyun
    Seo, Jae-Bin
    Chung, Woo-Young
    Zo, Joo-Hee
    Kim, Myung-A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C155 - C155
  • [25] EFFICACY AND SAFETY OF FIXED-DOSE COMBINATION OF IRBESARTAN/ROSUVASTATIN IN PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA
    Kim, S.
    Lee, H. L.
    Kim, H. R.
    Seo, J. B.
    Chung, W. Y.
    Zo, J. H.
    Kim, M. A.
    JOURNAL OF HYPERTENSION, 2015, 33 : E321 - E322
  • [26] How to increase the adherence to treatment of patients with arterial hypertension and dyslipidemia: focus on fixed combination of amlodipine and atorvastatin
    Lopatin, Yu. M.
    KARDIOLOGIYA, 2010, 50 (07) : 83 - 90
  • [27] A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension
    Kim, Woohyeun
    Chang, Kiyuk
    Cho, Eun Joo
    Ahn, Jeong-Cheon
    Yu, Cheol Woong
    Cho, Kyoung-Im
    Kim, Yong-Jin
    Kang, Duk-Hyun
    Kim, Seok-Yeon
    Lee, Sang-Hak
    Kim, Ung
    Kim, Shin-Jae
    Ahn, Young Keun
    Lee, Chang Hoon
    Shin, Jin Ho
    Kim, Mikyung
    Park, Chang Gyu
    JOURNAL OF CLINICAL HYPERTENSION, 2020, 22 (02): : 261 - 269
  • [28] Efficacy of Fixed-Dose Combination Therapy in the Treatment of Patients with Hypertension Focus on Amlodipine/Valsartan
    da Silva, Pedro Marques
    CLINICAL DRUG INVESTIGATION, 2010, 30 (09) : 625 - 641
  • [29] EFFECT OF SINGLE TABLET OF FIXED-DOSE AMLODIPINE AND ATORVASTATIN ON BLOOD PRESSURE AND LIPID PROFILE IN YOUNG PATIENTS
    Stancheva, N.
    Yakova, D.
    Chakalova, T.
    Yanakieva, A.
    Hristov, M.
    Tisheva, S. N.
    JOURNAL OF HYPERTENSION, 2015, 33 : E192 - E192
  • [30] Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects
    Oh, Minkyung
    Shin, Jae-Gook
    Ahn, Sangzin
    Kim, Bo Hoon
    Kim, Ji Yeon
    Shin, Hyun Ju
    Ghim, Jong-Lyul
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 991 - 997
12345